Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B

BACKGROUND: Partial or an entire deletion of SHANK3 are considered as major drivers in the Phelan–McDermid syndrome, in which 75% of patients are diagnosed with autism spectrum disorder (ASD). During the recent years, there was an increasing interest in stem cell therapy in ASD, and specifically, me...

Descripción completa

Detalles Bibliográficos
Autores principales: Perets, N., Oron, O., Herman, S., Elliott, E., Offen, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433169/
https://www.ncbi.nlm.nih.gov/pubmed/32807217
http://dx.doi.org/10.1186/s13229-020-00366-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433169/
https://www.ncbi.nlm.nih.gov/pubmed/32807217
http://dx.doi.org/10.1186/s13229-020-00366-x

Ejemplares similares